Table 3. Univariate and multivariate analyses of post-ENBD cholangitis.
Cholangitis | Univariate | Multivariate | |||
Variables | With (n = 75) | Without (n = 296) | P | OR (95 % CI) | P |
Age, y (range) | 0.611 | ||||
68.0 (34 – 83) | 68.5 (35 – 90) | ||||
Gender | 0.029 | 0.057 | |||
|
40 | 198 | |||
|
35 | 98 | |||
Bismuth-Corlette criteria | 0.016 | 0.082 | |||
|
10 | 79 | |||
|
65 | 217 | |||
Pre-ENBD cholangitis | 0.002 | 0.003 | |||
|
18 | 31 | 2.77 (1.40 – 5.46) | ||
|
57 | 265 | 1 | ||
Pre-ENBD total serum bilirubin | 0.132 | ||||
|
35 | 110 | |||
|
40 | 186 | |||
Previous EBS | 0.005 | 0.175 | |||
|
41 | 109 | |||
|
34 | 187 | |||
Previous EST | < 0.001 | 0.002 | |||
|
38 | 87 | 2.31 (1.35 – 3.95) | ||
|
37 | 209 | 1 | ||
Pancreatography | 0.636 | ||||
|
27 | 98 | |||
|
48 | 198 | |||
ENBD | 0.006 | 0.002 | |||
|
59 | 183 | 2.76 (1.45 – 5.26) | ||
|
16 | 113 | 1 | ||
Duration of ENBD, d (range) | 0.007 | 1.02 (1.01 – 1.03) | 0.002 | ||
36 (5 – 96) | 29 (2 – 144) |
ENBD, endoscopic nasobiliary drainage; EBS, endoscopic biliary stenting; EST, endoscopic sphincterotomy; c-ENBD, conventional ENBD catheter; m-ENBD, modified ENBD catheter